Impaired function of regulatory T-cells in patients with chronic obstructive pulmonary disease (COPD) (original) (raw)

Abstract

Anti-inflammatory pathways affecting chronic obstructive pulmonary disease (COPD) are poorly understood. Regulatory T-cells (Tregs) are important negative regulators of T-cell activity and hence were investigated in COPD patients in this study. We hypothesised that functional defects in Tregs may promote increased inflammation contributing to the pathogenesis of COPD. Peripheral blood mononuclear cells (PBMC) were isolated from patients with stable COPD and age-matched non-smoking controls. Treg-mediated suppression of memory non-Treg (Foxp3(-)CD45RO(+)) CD4(+) T-cell activation was analysed by comparing PBMC responses to staphylococcal enterotoxin-B (SEB) pre- and post-depletion of Tregs (CD25(+)CD127(low)CD4(+) T-cells) by fluorescence-activated cell sorting (FACS). Activation of T-cells was assessed by HLA-DR expression. Levels of secreted cytokines were measured by ELISA. Depletion of Tregs increased SEB-induced activation of Foxp3(-)CD45RO(+) CD4(+) T-cells in samples from 15/1...

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (32)

  1. Alcorn, J.F., Crowe, C.R., Kolls, J.K., 2010. TH17 cells in asthma and COPD. Annu. Rev. Physiol. 72, 495-516.
  2. Barcelo, B., Pons, J., Ferrer, J.M., Sauleda, J., Fuster, A., Agusti, A.G., 2008. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking. Eur. Respir. J. 31, 555-562.
  3. Barnes, P.J., Celli, B.R., 2009. Systemic manifestations and comorbidities of COPD. Eur. Respir. J. 33, 1165-1185.
  4. Chrysofakis, G., Tzanakis, N., Kyriakoy, D., Tsoumakidou, M., Tsiligianni, I., Klimath- ianaki, M., Siafakas, N.M., 2004. Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD. Chest 125, 71-76.
  5. Chu, S., Zhong, X., Zhang, J., Lao, Q., He, Z., Bai, J., 2011a. The expression of Foxp3 and ROR gamma t in lung tissues from normal smokers and chronic obstructive pulmonary disease patients. Int. Immunopharmacol.
  6. Chu, S., Zhong, X., Zhang, J., Lao, Q., He, Z., Bai, J., 2011b. The expression of Foxp3 and ROR gamma t in lung tissues from normal smokers and chronic obstructive pulmonary disease patients. Int. Immunopharmacol. 11, 1780-1788.
  7. Cosio, M.G., Saetta, M., Agusti, A., 2009. Immunologic aspects of chronic obstructive pulmonary disease. N. Engl. J. Med. 360, 2445-2454.
  8. Di Stefano, A., Caramori, G., Gnemmi, I., Contoli, M., Vicari, C., Capelli, A., Magno, F., D'Anna, S.E., Zanini, A., Brun, P., Casolari, P., Chung, K.F., Barnes, P.J., Papi, A., Adcock, I., Balbi, B., 2009. T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary dis- ease patients. Clin. Exp. Immunol. 157, 316-324.
  9. Finney, O.C., Riley, E.M., Walther, M., 2010. Phenotypic analysis of human periph- eral blood regulatory T cells (CD4+FOXP3+CD127lo/-) ex vivo and after in vitro restimulation with malaria antigens. Eur. J. Immunol. 40, 47-60.
  10. Han, J.M., Patterson, S.J., Speck, M., Ehses, J.A., Levings, M.K., 2014. Insulin inhibits IL-10-mediated regulatory T cell function: implications for obesity. J. Immunol. 192, 623-629.
  11. Hogg, J.C., Chu, F., Utokaparch, S., Woods, R., Elliott, W.M., Buzatu, L., Cherniack, R.M., Rogers, R.M., Sciurba, F.C., Coxson, H.O., Pare, P.D., 2004. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350, 2645-2653.
  12. Hou, J., Sun, Y., Hao, Y., Zhuo, J., Liu, X., Bai, P., Han, J., Zheng, X., Zeng, H., 2013. Imbalance between subpopulations of regulatory T cells in COPD. Thorax 68, 1131-1139.
  13. Isajevs, S., Taivans, I., Strazda, G., Kopeika, U., Bukovskis, M., Gordjusina, V., Kra- tovska, A., 2009. Decreased FOXP3 expression in small airways of smokers with COPD. Eur. Respir. J. 33, 61-67.
  14. Liu, W., Putnam, A.L., Xu-Yu, Z., Szot, G.L., Lee, M.R., Zhu, S., Gottlieb, P.A., Kapra- nov, P., Gingeras, T.R., Fazekas de St Groth, B., Clayberger, C., Soper, D.M., Ziegler, S.F., Bluestone, J.A., 2006. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 203, 1701-1711.
  15. Majo, J., Ghezzo, H., Cosio, M.G., 2001. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur. Respir. J. 17, 946-953.
  16. Mannino, D.M., Homa, D.M., Akinbami, L.J., Ford, E.S., Redd, S.C., 2002. Chronic obstructive pulmonary disease surveillance -United States, 1971-2000. Respir. Care 47, 1184-1199.
  17. Matarese, G., Procaccini, C., De Rosa, V., Horvath, T.L., La Cava, A., 2010. Regulatory T cells in obesity: the leptin connection. Trends Mol. Med. 16, 247-256.
  18. Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., Mathian, A., Nakahata, T., Yamaguchi, T., Nomura, T., Ono, M., Amoura, Z., Gorochov, G., Sakaguchi, S., 2009. Functional delineation and dif- ferentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30, 899-911.
  19. Paats, M.S., Bergen, I.M., Hoogsteden, H.C., van der Eerden, M.M., Hendriks, R.W., 2011. Systemic CD4+ and CD8+ T-cell cytokine profiles correlate with GOLD stage in stable COPD. Eur. Respir. J. 40, 330-337.
  20. Plumb, J., Smyth, L.J., Adams, H.R., Vestbo, J., Bentley, A., Singh, S.D., 2009. Increased T-regulatory cells within lymphocyte follicles in moderate COPD. Eur. Respir. J. 34, 89-94.
  21. Profita, M., Albano, G.D., Riccobono, L., Di Sano, C., Montalbano, A.M., Gagliardo, R., Anzalone, G., Bonanno, A., Pieper, M.P., Gjomarkaj, M., 2014. Increased levels of Th17 cells are associated with non-neuronal acetylcholine in COPD patients. Immunobiology 219, 392-401.
  22. Rabe, K.F., Hurd, S., Anzueto, A., Barnes, P.J., Buist, S.A., Calverley, P., Fukuchi, Y., Jenk- ins, C., Rodriguez-Roisin, R., van Weel, C., Zielinski, J., 2007. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 176, 532-555.
  23. Rivera, R.M., Cosio, M.G., Ghezzo, H., Salazar, M., Perez-Padilla, R., 2008. Comparison of lung morphology in COPD secondary to cigarette and biomass smoke. Int. J. Tuberc. Lung Dis. 12, 972-977.
  24. Roos-Engstrand, E., Ekstrand-Hammarstrom, B., Pourazar, J., Behndig, A.F., Bucht, A., Blomberg, A., 2009. Influence of smoking cessation on airway T lymphocyte subsets in COPD. COPD 6, 112-120.
  25. Sakaguchi, S., Wing, K., Yamaguchi, T., 2009. Dynamics of peripheral tolerance and immune regulation mediated by Treg. Eur. J. Immunol. 39, 2331-2336.
  26. Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S.I., Nanan, R., Kelleher, A., Fazekas de St Groth, B., 2006. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203, 1693-1700.
  27. Sinden, N.J., Stockley, R.A., 2010. Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence. Thorax 65, 930-936.
  28. Smyth, L.J., Starkey, C., Vestbo, J., Singh, D., 2007. CD4-regulatory cells in COPD patients. Chest 132, 156-163.
  29. Takabatake, N., Nakamura, H., Abe, S., Inoue, S., Hino, T., Saito, H., Yuki, H., Kato, S., Tomoike, H., 2000. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 161, 1179-1184.
  30. Vargas-Rojas, M.I., Ramirez-Venegas, A., Limon-Camacho, L., Ochoa, L., Hernandez- Zenteno, R., Sansores, R.H., 2011. Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease. Respir. Med. 105, 1648-1654.
  31. Wagner, N.M., Brandhorst, G., Czepluch, F., Lankeit, M., Eberle, C., Herzberg, S., Faustin, V., Riggert, J., Oellerich, M., Hasenfuss, G., Konstantinides, S., Schafer, K., 2013. Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk. Obesity (Silver Spring) 21, 461-468.
  32. Walker, L.S., Sansom, D.M., 2011. The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses. Nat. Rev. Immunol. 11, 852-863.